{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:27:28Z","timestamp":1784309248773,"version":"3.55.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015691","name":"Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272200800026C"],"award-info":[{"award-number":["HHSN272200800026C"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["K23MH090923"],"award-info":[{"award-number":["K23MH090923"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 67-4198"],"award-info":[{"award-number":["T32 67-4198"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AI027757"],"award-info":[{"award-number":["P30 AI027757"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.idc.2013.08.001","type":"journal-article","created":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T17:07:14Z","timestamp":1383239234000},"page":"723-737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Control of Neisseria gonorrhoeae in the Era of Evolving Antimicrobial Resistance"],"prefix":"10.1016","volume":"27","author":[{"given":"Lindley A.","family":"Barbee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia C.","family":"Dombrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idc.2013.08.001_bib1","series-title":"WHO. Global incidence and prevalence of selected curable sexually transmitted infections\u20142008","year":"2012"},{"key":"10.1016\/j.idc.2013.08.001_bib2","series-title":"Sexually transmitted disease surveillance, 2010","author":"CDC","year":"2011"},{"key":"10.1016\/j.idc.2013.08.001_bib3","series-title":"Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases","article-title":"\u201cNeisseria Gonorrhoeae\u201d","author":"Marrazzo","year":"2010"},{"issue":"1","key":"10.1016\/j.idc.2013.08.001_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/sti.75.1.3","article-title":"From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection","volume":"75","author":"Fleming","year":"1999","journal-title":"Sex Transm Infect"},{"issue":"6","key":"10.1016\/j.idc.2013.08.001_bib5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJMp1112456","article-title":"The emerging threat of untreatable gonococcal infection","volume":"366","author":"Bolan","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2013.08.001_bib6","series-title":"Sexually transmitted disease surveillance, 2011","author":"CDC","year":"2012"},{"issue":"5 Pt 1","key":"10.1016\/j.idc.2013.08.001_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.7326\/0003-4819-158-5-201303050-00004","article-title":"Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the gonococcal isolate surveillance project, 2005-2010","volume":"158","author":"Kirkcaldy","year":"2013","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.idc.2013.08.001_bib8","first-page":"1","article-title":"Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian regions, 2007-2008","volume":"34","author":"Tapsall","year":"2010","journal-title":"Commun Dis Intell"},{"issue":"42","key":"10.1016\/j.idc.2013.08.001_bib9","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.42.19995-en","article-title":"The European gonococcal antimicrobial surveillance programme, 2009","volume":"16","author":"Cole","year":"2011","journal-title":"Euro Surveill"},{"issue":"8","key":"10.1016\/j.idc.2013.08.001_bib10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.7326\/0003-4819-148-8-200804150-00005","article-title":"Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies","volume":"148","author":"Workowski","year":"2008","journal-title":"Ann Intern Med"},{"issue":"RR-11","key":"10.1016\/j.idc.2013.08.001_bib11","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2006","volume":"55","author":"Workowski","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"31","key":"10.1016\/j.idc.2013.08.001_bib12","first-page":"590","article-title":"Update to CDC's sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"10.1016\/j.idc.2013.08.001_bib13","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1128\/AAC.48.8.3185-3187.2004","article-title":"Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones","volume":"48","author":"Ito","year":"2004","journal-title":"Antimicrobial Agents Chemother"},{"issue":"10","key":"10.1016\/j.idc.2013.08.001_bib14","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1128\/AAC.00198-08","article-title":"Ceftibuten resistance and treatment failure of Neisseria gonorrhoeae infection","volume":"52","author":"Lo","year":"2008","journal-title":"Antimicrobial Agents Chemother"},{"issue":"11","key":"10.1016\/j.idc.2013.08.001_bib15","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/OLQ.0b013e31822e60a4","article-title":"Trends in antimicrobial resistance of Neisseria gonorrhoeae isolated from Korean patients from 2000 to 2006","volume":"38","author":"Lee","year":"2011","journal-title":"Sex Transm Dis"},{"issue":"1","key":"10.1016\/j.idc.2013.08.001_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.33321\/cdi.2012.36.4","article-title":"Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian Regions, 2010","volume":"36","author":"Lahra","year":"2012","journal-title":"Commun Dis Intell"},{"issue":"29","key":"10.1016\/j.idc.2013.08.001_bib17","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.29.20225-en","article-title":"Increasing trends of gonorrhoea and syphilis and the\u00a0threat of drug-resistant gonorrhoea in Europe","volume":"17","author":"Van de Laar","year":"2012","journal-title":"Euro Surveill"},{"key":"10.1016\/j.idc.2013.08.001_bib18","series-title":"Gonococcal antimicrobial susceptibility surveillance in Europe\u20142010","author":"European Centre for Disease Prevention and Control","year":"2012"},{"issue":"8","key":"10.1016\/j.idc.2013.08.001_bib19","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3201\/eid1308.060948","article-title":"Threat to cefixime treatment for gonorrhea","volume":"13","author":"Yokoi","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2013.08.001_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10156-002-0204-8","article-title":"Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval","volume":"9","author":"Deguchi","year":"2003","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.idc.2013.08.001_bib21","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2217\/fmb.12.117","article-title":"Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea","volume":"7","author":"Unemo","year":"2012","journal-title":"Future Microbiol"},{"issue":"47","key":"10.1016\/j.idc.2013.08.001_bib22","doi-asserted-by":"crossref","DOI":"10.2807\/ese.15.47.19721-en","article-title":"Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010","volume":"15","author":"Unemo","year":"2010","journal-title":"Euro Surveill"},{"issue":"14","key":"10.1016\/j.idc.2013.08.001_bib23","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.14.19833-en","article-title":"Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010","volume":"16","author":"Ison","year":"2011","journal-title":"Euro Surveill"},{"issue":"43","key":"10.1016\/j.idc.2013.08.001_bib24","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.43.19998-en","article-title":"First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011","volume":"16","author":"Unemo","year":"2011","journal-title":"Euro Surveill"},{"issue":"3","key":"10.1016\/j.idc.2013.08.001_bib25","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure","volume":"56","author":"Unemo","year":"2012","journal-title":"Antimicrobial Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2013.08.001_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2012.176575","article-title":"Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada","volume":"309","author":"Allen","year":"2013","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.idc.2013.08.001_bib27","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1128\/AAC.00325-11","article-title":"Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone","volume":"55","author":"Ohnishi","year":"2011","journal-title":"Antimicrobial Agents Chemother"},{"issue":"6","key":"10.1016\/j.idc.2013.08.001_bib28","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.06.19792-en","article-title":"Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010","volume":"16","author":"Unemo","year":"2011","journal-title":"Euro Surveill"},{"issue":"25","key":"10.1016\/j.idc.2013.08.001_bib29","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.25.20200-en","article-title":"Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011","volume":"17","author":"Unemo","year":"2012","journal-title":"Euro Surveill"},{"issue":"4","key":"10.1016\/j.idc.2013.08.001_bib30","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.eimc.2011.11.010","article-title":"First cases of Neisseria gonorrhoeae resistant to ceftriaxone in Catalonia, Spain, May 2011","volume":"30","author":"Carnicer-Pont","year":"2012","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.idc.2013.08.001_bib31","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1111\/j.1749-6632.2011.06215.x","article-title":"Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future","volume":"1230","author":"Unemo","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.idc.2013.08.001_bib32","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1128\/AAC.01604-06","article-title":"Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA","volume":"51","author":"Lindberg","year":"2007","journal-title":"Antimicrobial Agents Chemother"},{"issue":"4","key":"10.1016\/j.idc.2013.08.001_bib33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1056\/NEJM197301252880404","article-title":"Clinical spectrum of pharyngeal gonococcal infection","volume":"288","author":"Wiesner","year":"1973","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.idc.2013.08.001_bib34","first-page":"491","article-title":"Gonococcal pharyngeal infections. Report of 110 cases","volume":"49","author":"Bro-Jorgensen","year":"1973","journal-title":"Br J Vener Dis"},{"issue":"23","key":"10.1016\/j.idc.2013.08.001_bib35","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1001\/jama.1981.03320230041022","article-title":"Pharyngeal gonorrhea","volume":"246","author":"Tice","year":"1981","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.idc.2013.08.001_bib36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/sti.2010.043349","article-title":"Pharyngeal gonorrhoea: a silent cause for concern","volume":"86","author":"Kinghorn","year":"2010","journal-title":"Sex Transm Infect"},{"issue":"10","key":"10.1016\/j.idc.2013.08.001_bib37","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/OLQ.0b013e31822a2b2e","article-title":"Infections missed by urethral-only screening for chlamydia or gonorrhea detection among men who have sex with men","volume":"38","author":"Marcus","year":"2011","journal-title":"Sex Transm Dis"},{"issue":"1","key":"10.1016\/j.idc.2013.08.001_bib38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1086\/430704","article-title":"Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003","volume":"41","author":"Kent","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"RR-12","key":"10.1016\/j.idc.2013.08.001_bib39","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2010","volume":"59","author":"Workowski","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"10.1016\/j.idc.2013.08.001_bib40","first-page":"92","article-title":"Response of pharyngeal gonorrhoea to single dose penicillin treatment","volume":"63","author":"Sulaiman","year":"1987","journal-title":"Genitourin Med"},{"issue":"1","key":"10.1016\/j.idc.2013.08.001_bib41","first-page":"64","article-title":"Oropharyngeal carriage of Neisseria gonorrhoeae and its response to treatment in patients with anogenital infection","volume":"64","author":"Ahmed-Jushuf","year":"1988","journal-title":"Genitourin Med"},{"issue":"1","key":"10.1016\/j.idc.2013.08.001_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00007435-198001000-00001","article-title":"Correlation of auxotype and penicillin susceptibility of Neisseria gonorrhoeae with sexual preference and clinical manifestations of gonorrhea","volume":"7","author":"Handsfield","year":"1980","journal-title":"Sex Transm Dis"},{"issue":"4","key":"10.1016\/j.idc.2013.08.001_bib43","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jpag.2010.02.003","article-title":"Culture of non-genital sites increases the detection of gonorrhea in women","volume":"23","author":"Giannini","year":"2010","journal-title":"J\u00a0Pediatr Adolesc Gynecol"},{"issue":"6","key":"10.1016\/j.idc.2013.08.001_bib44","first-page":"408","article-title":"Prevalence of rectal and pharyngeal infection in women with gonorrhoea in Sheffield","volume":"55","author":"Kinghorn","year":"1979","journal-title":"Br J Vener Dis"},{"issue":"2","key":"10.1016\/j.idc.2013.08.001_bib45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1258\/ijsa.2009.009076","article-title":"Audit of routine rectal swabs for gonorrhoea culture in women","volume":"21","author":"Raychaudhuri","year":"2010","journal-title":"Int J STD AIDS"},{"issue":"12","key":"10.1016\/j.idc.2013.08.001_bib46","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/OLQ.0b013e31826ae9a2","article-title":"Prevalence and correlates of rectal chlamydia and gonorrhea among female clients at sexually transmitted disease clinics","volume":"39","author":"Javanbakht","year":"2012","journal-title":"Sex Transm Dis"},{"issue":"7","key":"10.1016\/j.idc.2013.08.001_bib47","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/OLQ.0b013e31817bdd7e","article-title":"Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men","volume":"35","author":"Schachter","year":"2008","journal-title":"Sex Transm Dis"},{"issue":"5","key":"10.1016\/j.idc.2013.08.001_bib48","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1128\/JCM.02398-09","article-title":"Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections","volume":"48","author":"Bachmann","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"issue":"4","key":"10.1016\/j.idc.2013.08.001_bib49","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1128\/JCM.01581-08","article-title":"Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae oropharyngeal infections","volume":"47","author":"Bachmann","year":"2009","journal-title":"J\u00a0Clin Microbiol"},{"issue":"9","key":"10.1016\/j.idc.2013.08.001_bib50","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1128\/AAC.00406-09","article-title":"Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California","volume":"53","author":"Pandori","year":"2009","journal-title":"Antimicrobial Agents Chemother"},{"issue":"12","key":"10.1016\/j.idc.2013.08.001_bib51","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/01.olq.0000190092.59482.96","article-title":"Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections","volume":"32","author":"Schachter","year":"2005","journal-title":"Sex Transm Dis"},{"issue":"9","key":"10.1016\/j.idc.2013.08.001_bib52","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1128\/JCM.41.9.4395-4399.2003","article-title":"Comparing first-void urine specimens, self-collected vaginal swabs, and endocervical specimens to detect Chlamydia trachomatis and Neisseria gonorrhoeae by a nucleic acid amplification test","volume":"41","author":"Shafer","year":"2003","journal-title":"J\u00a0Clin Microbiol"},{"issue":"2","key":"10.1016\/j.idc.2013.08.001_bib53","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1586\/eri.10.164","article-title":"Home versus clinic-based specimen collection for Chlamydia trachomatis and Neisseria gonorrhoeae","volume":"9","author":"Graseck","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"8","key":"10.1016\/j.idc.2013.08.001_bib54","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.2105\/AJPH.2012.301010","article-title":"There's no place like home: first-year use of the \u201cI know\u201d home testing program for chlamydia and gonorrhea","volume":"103","author":"Rotblatt","year":"2013","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.idc.2013.08.001_bib55","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/AOG.0b013e3181d4450d","article-title":"Home screening compared with clinic-based screening for sexually transmitted infections","volume":"115","author":"Graseck","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.idc.2013.08.001_bib56","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/01.olq.0000190057.61633.8d","article-title":"Women find it easy and prefer to collect their own vaginal swabs to diagnose Chlamydia trachomatis or Neisseria gonorrhoeae infections","volume":"32","author":"Chernesky","year":"2005","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.idc.2013.08.001_bib57","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00007435-200106000-00003","article-title":"Self-collection of vaginal swabs for the detection of Chlamydia, gonorrhea, and trichomoniasis: opportunity to encourage sexually transmitted disease testing among adolescents","volume":"28","author":"Wiesenfeld","year":"2001","journal-title":"Sex Transm Dis"},{"issue":"11","key":"10.1016\/j.idc.2013.08.001_bib58","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/OLQ.0b013e318227713e","article-title":"Evaluation of self-collected versus clinician-collected swabs for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae pharyngeal infection among men who have sex with men","volume":"38","author":"Freeman","year":"2011","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.idc.2013.08.001_bib59","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/sti.2008.031443","article-title":"Self-taken pharyngeal and rectal swabs are appropriate for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in asymptomatic men who have sex with men","volume":"84","author":"Alexander","year":"2008","journal-title":"Sex Transm Infect"},{"issue":"2","key":"10.1016\/j.idc.2013.08.001_bib60","first-page":"70","article-title":"How reliable is self-testing for gonorrhea and chlamydia among men who have sex with men?","volume":"62","author":"Sexton","year":"2013","journal-title":"J\u00a0Fam Pract"},{"issue":"3","key":"10.1016\/j.idc.2013.08.001_bib61","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/13691058.2010.535018","article-title":"Home sampling kits for sexually transmitted infections: preferences and concerns of men who have sex with men","volume":"13","author":"Wayal","year":"2011","journal-title":"Cult Health Sex"},{"issue":"1","key":"10.1016\/j.idc.2013.08.001_bib62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00007435-199501000-00007","article-title":"Treating uncomplicated Neisseria gonorrhoeae infections: is the anatomic site of infection important?","volume":"22","author":"Moran","year":"1995","journal-title":"Sex Transm Dis"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2013.08.001_bib63","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/clinids\/20.Supplement_1.S47","article-title":"Drugs of choice for the treatment of uncomplicated gonococcal infections","volume":"20","author":"Moran","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2013.08.001_bib64","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1086\/648428","article-title":"Pharyngeal gonorrhea: an important reservoir of infection?","volume":"49","author":"Weinstock","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2013.08.001_bib65","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/jac\/dks188","article-title":"The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting","volume":"67","author":"Whiley","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.idc.2013.08.001_bib66","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/cid\/cit084","article-title":"A\u00a0retrospective comparative study of two-drug oral and intramuscular cephalosporin treatment regimens for pharyngeal gonorrhea","volume":"56","author":"Barbee","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2013.08.001_bib67","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1258\/095646207781568556","article-title":"Pharyngeal gonorrhoea\u2014is dual therapy the way forward?","volume":"18","author":"Sathia","year":"2007","journal-title":"Int J STD AIDS"},{"issue":"10","key":"10.1016\/j.idc.2013.08.001_bib68","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1258\/ijsa.2011.011267","article-title":"UK national guideline for the management of gonorrhoea in adults, 2011","volume":"22","author":"Bignell","year":"2011","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.idc.2013.08.001_bib69","unstructured":"Public Health Agency of Canada. Important notice on gonococcal infection. 2011. Available at: http:\/\/www.phac-aspc.gc.ca\/std-mts\/sti-its\/alert\/2011\/alert-gono-eng.php. Accessed February 4, 2013."},{"key":"10.1016\/j.idc.2013.08.001_bib70","unstructured":"Workowski K. Treatment in an era of dwindling treatment options. Oral presentation at the CDC National STD Prevention Conference 2012. Minneapolis, March 12\u201315, 2012."},{"issue":"3","key":"10.1016\/j.idc.2013.08.001_bib71","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1128\/AAC.01343-09","article-title":"In\u00a0vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae","volume":"54","author":"Roblin","year":"2010","journal-title":"Antimicrobial Agents Chemother"},{"issue":"7","key":"10.1016\/j.idc.2013.08.001_bib72","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1128\/AAC.00326-12","article-title":"In\u00a0vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea?","volume":"56","author":"Unemo","year":"2012","journal-title":"Antimicrobial Agents Chemother"},{"issue":"3","key":"10.1016\/j.idc.2013.08.001_bib73","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/OLQ.0b013e3181bf575c","article-title":"Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007","volume":"37","author":"Brown","year":"2010","journal-title":"Sex Transm Dis"},{"issue":"8","key":"10.1016\/j.idc.2013.08.001_bib74","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/sextrans-2012-050604","article-title":"Effectiveness of gentamicin for gonorrhoea treatment: systematic review and meta-analysis","volume":"88","author":"Dowell","year":"2012","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.idc.2013.08.001_bib75","unstructured":"Kircaldy R. Treatment of gonorrhea in an era of emerging cephalosporin resistance. STI & AIDS World Congress. Vienna, Austria, July 16, 2013."},{"issue":"8","key":"10.1016\/j.idc.2013.08.001_bib76","doi-asserted-by":"crossref","first-page":"564","DOI":"10.7326\/0003-4819-145-8-200610170-00005","article-title":"High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening","volume":"145","author":"Peterman","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.idc.2013.08.001_bib77","series-title":"CDC. Cephalosporin-resistant Neisseria gonorrhoeae public health response plan","year":"2012"},{"issue":"7","key":"10.1016\/j.idc.2013.08.001_bib78","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa041681","article-title":"Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection","volume":"352","author":"Golden","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2013.08.001_bib79","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fmicb.2011.00124","article-title":"Vaccines for gonorrhea: can we rise to the challenge?","volume":"2","author":"Zhu","year":"2011","journal-title":"Front Microbiol"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552013000640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552013000640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:45:15Z","timestamp":1778633115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552013000640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0891552013000640"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2013.08.001","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Control of Neisseria gonorrhoeae in the Era of Evolving Antimicrobial Resistance","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2013.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}